MITSY vs. NVO
MITSY (Mitsui & Company Ltd) and NVO (Novo Nordisk A/S) are both stocks. MITSY operates in Conglomerates (Industrials), while NVO operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, MITSY returned 18.03%/yr vs 8.18%/yr for NVO. At a 0.18 correlation, their price movements are largely independent.
Performance
MITSY vs. NVO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MITSY achieves a -0.95% return, which is significantly lower than NVO's 0.91% return. Over the past 10 years, MITSY has outperformed NVO with an annualized return of 18.03%, while NVO has yielded a comparatively lower 8.18% annualized return.
MITSY
- 1D
- 0.40%
- 1M
- -1.39%
- 6M
- -10.82%
- YTD
- -0.95%
- 1Y
- 44.63%
- 3Y*
- 16.33%
- 5Y*
- 21.42%
- 10Y*
- 18.03%
- ALL TIME*
- 8.98%
NVO
- 1D
- -1.41%
- 1M
- 14.86%
- 6M
- -17.63%
- YTD
- 0.91%
- 1Y
- -19.26%
- 3Y*
- -13.51%
- 5Y*
- 4.43%
- 10Y*
- 8.18%
- ALL TIME*
- 14.52%
MITSY vs. NVO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
MITSY Mitsui & Company Ltd | -0.95% | 43.31% | 13.10% | 28.00% | 23.12% | 28.70% | 4.06% | 14.13% | -4.90% | 20.93% |
NVO Novo Nordisk A/S | 0.91% | -39.22% | -15.93% | 54.84% | 22.66% | 63.52% | 23.33% | 28.70% | -12.98% | 52.92% |
Correlation
The correlation between MITSY and NVO is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.17 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.20 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.16 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.15 |
Correlation (All Time) Calculated using the full available price history since Apr 25, 2011 | 0.18 |
Fundamentals
MITSY:
$82.23B
NVO:
$220.46B
MITSY:
¥5.90K
NVO:
DKK 27.42
MITSY:
15.99
NVO:
11.83
MITSY:
4.62
NVO:
0.51
MITSY:
0.95
NVO:
4.40
MITSY:
1.53
NVO:
7.11
MITSY:
¥14.19T
NVO:
DKK 327.80B
MITSY:
¥1.35T
NVO:
DKK 268.30B
MITSY:
¥1.01T
NVO:
DKK 181.54B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MITSY vs. NVO — Risk / Return Rank
MITSY
NVO
MITSY vs. NVO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Mitsui & Company Ltd (MITSY) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MITSY | NVO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.81 | ||
| Sortino ratioReturn per unit of downside risk | +2.25 | ||
| Omega ratioGain probability vs. loss probability | 1.25 | 0.97 | +0.28 |
| Calmar ratioReturn relative to maximum drawdown | 1.36 | -0.39 | +1.75 |
| Martin ratioReturn relative to average drawdown | 3.97 | -0.61 | +4.58 |
Loading charts...
Drawdowns
MITSY vs. NVO - Drawdown Comparison
The maximum MITSY drawdown since its inception was -44.45%, smaller than the maximum NVO drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for MITSY and NVO.
Loading charts...
Drawdown Indicators
| MITSY | NVO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -44.45% | -74.70% | +30.25% |
Max Drawdown (1Y)Largest decline over 1 year | -32.95% | -49.17% | +16.22% |
Max Drawdown (3Y)Largest decline over 3 years | -33.95% | -74.70% | +40.75% |
Max Drawdown (5Y)Largest decline over 5 years | -33.95% | -74.70% | +40.75% |
Max Drawdown (10Y)Largest decline over 10 years | -33.95% | -74.70% | +40.75% |
Current DrawdownCurrent decline from peak | -28.74% | -63.95% | +35.21% |
Average DrawdownAverage peak-to-trough decline | -16.15% | -17.89% | +1.74% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.27% | 31.75% | -20.48% |
Volatility
MITSY vs. NVO - Volatility Comparison
The current volatility for Mitsui & Company Ltd (MITSY) is 8.01%, while Novo Nordisk A/S (NVO) has a volatility of 9.48%. This indicates that MITSY experiences smaller price fluctuations and is considered to be less risky than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MITSY | NVO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.01% | 9.48% | -1.47% |
Volatility (6M)Calculated over the trailing 6-month period | 24.69% | 37.43% | -12.74% |
Volatility (1Y)Calculated over the trailing 1-year period | 31.20% | 51.79% | -20.59% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 29.77% | 38.58% | -8.81% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 26.82% | 32.63% | -5.81% |
Dividends
MITSY vs. NVO - Dividend Comparison
MITSY has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 3.63%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MITSY Mitsui & Company Ltd | 0.00% | 1.17% | 1.61% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.65% | 3.82% | 0.00% |
NVO Novo Nordisk A/S | 3.63% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
Financials
MITSY vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Mitsui & Company Ltd and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
MITSY vs. NVO - Profitability Comparison
MITSY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Mitsui & Company Ltd reported a gross profit of 368.30B and revenue of 3.71T. Therefore, the gross margin over that period was 9.9%.
NVO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.
MITSY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Mitsui & Company Ltd reported an operating income of 106.13B and revenue of 3.71T, resulting in an operating margin of 2.9%.
NVO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.
MITSY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Mitsui & Company Ltd reported a net income of 226.10B and revenue of 3.71T, resulting in a net margin of 6.1%.
NVO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.
Frequently Asked Questions
MITSY and NVO have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NVO has higher volatility (9.48%) compared to MITSY (8.01%). In terms of maximum drawdown, MITSY dropped -44.45% vs NVO's -74.70%.
MITSY currently has the higher Sharpe Ratio (1.44 vs -0.37), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MITSY and NVO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer